Promoting mechanisms of CO2 on neuroendocrine cell proliferation mediated by nicotinic receptor stimulation: Significance for lung cancer risk in individuals with chronic lung disease

Chest

Volumn 109, Issue 3 SUPPL., 1996, Pages

  Schuller, Hildegard M ^a   Miller, M S ^a   Park, P G ^a   Orloff, Mark S ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINIC RECEPTOR; CARBON DIOXIDE;

ANIMAL CELL; CANCER RISK; CARBON DIOXIDE MEASUREMENT; CARBON DIOXIDE TENSION; CELL PROLIFERATION; CHOLINERGIC TRANSMISSION; CHRONIC LUNG DISEASE; CONFERENCE PAPER; HAMSTER; LUNG CANCER; LUNG DISEASE; LUNG VENTILATION; NEUROSECRETORY CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; ANIMAL; ARTICLE; CARCINOMA; CELL CULTURE; CELL DIVISION; CHRONIC DISEASE; HUMAN; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CARBON DIOXIDE; CARCINOMA, NEUROENDOCRINE; CELL DIVISION; CHRONIC DISEASE; CRICETINAE; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; RECEPTORS, NICOTINIC; TUMOR CELLS, CULTURED;

EID: 0029664496     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Weiss W. COPD and lung cancer. In: Cherniak NS, ed. Obstructive pulmonary disease. Philadelphia: WB Saunders, 1991; 344-47
2. Johnson DE, Geogieff MK. Pulmonary perspective: neuroendocrine cells in health and disease. Am Rev Respir Dis 1989; 140: 1807-12
3. Youngson C, Nurse C, Yeger H, et al. Oxygen sensing in airway chemoreceptors. Nature 1993; 363:153-55
4. Willey JC, Lechner JF, Harris CC. Bombesin and the C-terminal tetradecapeptide of gastrin-releasing peptide as growth factors for normal human bronchial epithelial cells. Exp Cell Res 1984; 153:245-51
5. Nylen ES, Linnoila IR, Becker KL. Prenatal cholinergic stimulation of pulmonary neuroendocrine cells by nicotine. Acta Physiol Scand 1988; 132:117-18
6. Schuller HM. Carbon dioxide potentiates the mitogenic effects of nicotine and its carcinogenic derivative, NNK, in normal and neoplastic neuroendocrine lung cells via stimulation of autocrine and protein kinase C-dependent pathways. Neurotoxicology 1994; 15:877-86
7. Quik M, Chan J, Patrick J. α-Bungarotoxin blocks the nicotinic receptor-mediated increase in cell number in a neuroendocrine cell line. Brain Res 1994; 655:161-67
8. Gerber JG, Nies AS. Antihypertensive agents and the drug therapy of hypertension. In: Goodman Gilman A, Rall TW, Nies AS, et al, eds. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990; 784-813
9. Baldessarini RJ. Drugs and the treatment of psychiatric disorders. In: A Goodman Gilman A, Rall TW, Nies AS, et al, eds. The pharmacological basis of therapeutics. New York: Pergamon Press, 1990; 383-435
10. Fatal AM, Davila DG, Peters SG. Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 1993; 68:278-87
11. Schuller HM, Orloff M, Reznik G. Inhibition of protein kinase C-dependent cell proliferation of human lung cancer cell lines by the dihydropyridine dexniguldipine. J Cancer Res Clin Oncol 1994; 120:354-58
12. Bunn PA Jr. Growth factors and their receptors in the pathogenesis and prevention of lung cancer [abstract]. Proc Am Assoc Cancer Res 1994; 65:691